Follow our path with asparaginase activity: one technique, but different uses in clinical practice
Abstract Acute lymphoblastic leukemia is the most common childhood malignancy. One of the drugs used in the treatment is Asparaginase, and monitoring of its activity levels enables better outcomes. Since 2018, our laboratory has been working to establish a regular analysis of activity. This implemen...
Main Authors: | Daiane Keller Cecconello, Ciliana Rechenmacher, Klerize Anecely de Souza Silva, Fernanda Fetter Scherer, Thomas Dal Bem Prates, Rebeca Ferreira Marques, Liane Esteves Daudt, Mariana Bohns Michalowski |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40164-022-00351-5 |
Similar Items
-
Peg-asparaginase associated toxicities in children with acute lymphoblastic leukemia: A single-center cross-sectional study
by: Sameh Awwad, et al.
Published: (2024-03-01) -
Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen
by: Ibrahim Al Nabhani, et al.
Published: (2023-02-01) -
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL
by: Alexander Popov, et al.
Published: (2023-11-01) -
Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases
by: Judit Müller, et al.
Published: (2023-07-01) -
Isolation and Purification of L-Asparaginase from Persian Gulf Streptomyces Isolates and Evaluation of It’s Cloned Gene Expression in Escherichia Coli by Real-Time and SDS-PAGE
by: Hadiseh Soofer, et al.
Published: (2020-08-01)